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1. INTRODUCTION
The purpose of image-guided radiation therapy (IGRT)
[1] is to deliver precise radiation doses to target locations
in a patient using three-dimensional images obtained from
imaging devices attached to the medical LINAC. The
adaptive radiotherapy technique [2], one of the new tech-
niques in current radiotherapy, evolved from the IGRT
modality via monitoring of treatment volumes of a patient
using a high-performance imaging device such as a cone
beam computed tomography (CBCT) machine. Kilovolt
(kV) or megavolt (MV) based imaging devices [3] are
currently used in IGRT. Recently, more attention has been
paid to the additional imaging dose delivered to the patient
from the imaging devices, which might increase a secondary
cancer risk. Typically, the imaging dose has been signifi-
cantly studied in diagnostic radiation use but there is a lack
of experimental data on the imaging dose in CBCT. Goetti
et al. [4] measured imaging dose using a thermoluminescence
dosimeter (TLD) for two CBCTs in radiotherapy. However,
the TLD has high uncertainty because of a high response
to kV X-rays and directional dependency [5]. Hyer et al.
used optical-fiber-based scintillation detectors [6], but an
optical-fiber-based dosimetry device is not practical in a
clinical setting because of its complex configuration and
fragility [7]. As another approach, Hyer et al. studied the
conversion of imaging dose using software operated by
dose data for conventional CT scanners. As a result, large
differences from the measured data [8] were observed
because of the sensitivity of the organ doses to the scan
protocol (scan geometry, kV, and mAs). In this study,
effective doses from a CBCT machine for three typical
radiotherapy sites were evaluated by measuring individual
organ doses in an anthropomorphic physical phantom.
Commercial glass dosimeters, which were specially designed
for dosimetry in low-energy X-ray regions, were used in
the measurements. One of the advantages of the glass
dosimeter is the absence of directional dependency owing
to its cylindrical symmetry [9]. The measured organ doses
and effective doses are discussed in terms of patient safety
in radiotherapy.
2. MATERIAL AND METHODS 
2.1 CBCT System
The organ dose delivered from an X-ray volume imaging
CBCT system (XVITM, Elekta, UK) built into a medical
LINAC (InfinityTM, Elekta, UK)(Fig. 1) was measured
using a RANDO® phantom (The Phantom Laboratory,
USA) and glass dosimeter. The Elekta Infinity system is
a comprehensive treatment system that includes an IGRT
feature. 3-D image guidance is designed to reduce position
setup errors during treatment.
During image-guided radiation therapy, the patient is exposed to unwanted radiation from imaging devices built into the
medical LINAC. In the present study, the effective dose delivered to a patient from a cone beam computed tomography
(CBCT) machine was measured. Absorbed doses in specific organs listed in ICRP Publication 103 were measured with glass
dosimeters calibrated with kilovolt (kV) X-rays using a whole body physical phantom for typical radiotherapy sites, including
the head and neck, chest, and pelvis. The effective dose per scan for the head and neck, chest, and pelvis were 3.37±0.29,
7.36±0.33, and 4.09±0.29 mSv, respectively. The results highlight the importance of the compensation of treatment dose by
managing imaging dose.
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XVI is an electronic imaging device designed with a
kV X-ray source and flat-panel detector mounted on the
gantry for kV image acquisition. It provides more infor-
mation to set up the patient position more accurately for
treatment. The X-ray beam of the imaging system has the
same isocenter as the MV treatment beam. In this study, the
effective dose was evaluated using the scanning parameters
listed in Table 1. 
2.2 Physical Anthropomorphic Phantom
The RANDO® Woman phantom, which was used in
this study, represents a 163 cm tall and 54 kg female without
arms and legs as shown in Fig. 2. The phantom is con-
structed with the skeleton of a natural human, soft tissue
and lung material. The human skeleton is cast inside soft
tissue-simulating material; lungs are also molded to fit the
contours of the natural rib cage. The phantom is sliced at
an interval of 2.5 cm with holes in grid patterns, which
are drilled into the sliced sections to enable the insertion
of dosimeters.
2.3 The Beam Quality for kV X-ray from CBCT
In order to determine the X-ray beam quality, half-
value layer (HVL) or effective energy was used as the
beam quality index in the kV X-ray dosimetry protocol,
where the effective energy is defined as the energy of a
monoenergetic photon beam that yields the same HVL as
a heterogeneous beam. In this study, the HVL of 7 mm Al
was obtained from William et al. [10]. Then we determined
the effective energy from the relationship, HVL=0.693/µ,
where µ is the linear attenuation coefficient. The linear
attenuation coefficients and HVLs of aluminum as a func-
tion of energy are listed in Table 2 [11].
The fitting curve of the effective energies for the HVLs
of 4–12 mm Al is shown in Fig. 3.
The fitted equation for the effective energy according
to the HVL of Al is as follows:
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Fig. 1. Elekta Infinity System Equipped with XVI CBCT System
and RANDO Physical Phantom Placed on the Patient Bed
Fig. 2. Frontal View of the RANDO® Female Phantom.
Scan size ( for head, chest and pelvis scans)
26.5×26.5 cm2
Acquisition angle
180o-180o cc
Total mAs
1056
Frames
660
Gantry Speed
360 deg/min
kVp
120 
mA
40
Scan Condition
Table 1. Scanning Parameter
10
15
20
30
40
50
60
80
100
69.69
21.15
9.155
3.009
1.520
0.9865
0.7457
0.5430
0.4591
Energy (keV)
Half Value Layer
(mm Al)
Attenuation
coefficient of
aluminum  (1/cm)
0.09944
0.3277
0.7570
2.303
4.561
7.028
9.290
12.76
15.10
Table 2. Linear Attenuation Coefficients and HVLs of Aluminum
According to the Effective Energies
(1)
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where Eeff is effective energy and HVL is half-value layer.
The effective energy for XVI was 49.9 keV, which was
cal-culated using equation (1).
2.4 Dosimetry System
A glass dosimeter is an accumulation type solid state
dosimeter, which is based on the radiophotoluminescent
phenomenon of silver activated phosphate glass. The glass
dosimetry system is composed of rod-shaped silver activated
phosphate glass, a plastic capsule, and an automatic reader
unit. The weight compositions of the glass dosimeter are
as follows: P (31.55%), O (51.16%), Al (6.12%), Na (11.0%)
and Ag (0.17%). The effective atomic number and density
are 12.039 and 2.61 g/cm2 respectively. Measurable doses
range from 10 mGy to 10 Gy in standard mode and from
1 to 500 Gy in high dose mode. In this study, a GD352M
glass dosimeter (Asahi Techno Glass, Japan) designed for
low energy photon beams was used [12]. The GD352M
is shown in Fig. 4. In the figure a tin filter compensates
for the high response in low energy photons. Detailed
information for the glass dosimeter is described in ref. [13].
In air kerma based dosimetry, the absorbed dose in air
can be expressed by
where Dair and Kair are absorbed dose and kerma in air,
respectively, and g is the bremsstrahlung fraction. In
kilovoltage X-rays, g is generally ignored; therefore, the air
kerma becomes approximately the same as the absorbed
dose in air [14]. In this study, air kerma based dosimetry
was used. The reader was calibrated by air kerma for gamma
rays from a Cs-137 source. The variation of response in
different beam quality from Cs-137 gamma rays was care-
fully considered in reading the dosimeter. In order to correct
the beam quality, five glass dosimeters were exposed to
standard irradiation with M30, M60, M100, M150 kV X-
rays, and Cs-137 gamma rays in the standard dosimetry
laboratory of KAERI (Korea Atomic Energy Research
Institute). 
The beam quality factor k was inferred from the standard
irradiations. The k as a function of beam quality (Q) was
calculated by 
Therefore the absorbed dose in air for kV X-rays is
calculated by
where Dair,g is the absorbed dose in air for a beam quality
Q, and Dair,Qois the absorbed dose in air by reference beam
quality Q0. 
Effective energy was directly employed as the beam
quality parameter (Q = Eeff) and k (=1.040) was determined
for Eeff = 49.9 keV by a linear interpolation using relative
response data. The relative response normalized by Cs-
137 gamma rays is shown in Fig. 5. 
2.5 Measurement of Organ Doses
The phantom was positioned similarly to a real patient
being treated for a particular anatomical region to achieve
clinically suitable dose values. For head and neck scans,
Fig. 3. Effective Energy for HVLs of 4-12 mm Al and Fitting Curve
Fig. 5. Relative Response for Effective Energy
Fig. 4. Glass Dosimeter (GD352M) and Reader (FGD1000)
(2)
(3)
(4)
the phantom was aligned with the center of the philtrum
at isocenter of the treatment beam. The irradiated region
during CBCT included part of the esophagus, thyroid,
salivary glands, oral mucosa, extrathoracic region, and
brain. For chest scans, the beam isocenter was placed in
the center of the body at an axial plane near the center of
the lungs. The region of interest in the chest scan covered
the lungs, part of the esophagus, breast, liver, thymus,
heart, spleen, adrenals, pancreas, gall bladder, kidneys,
part of the small intestine, and stomach. For pelvis scans,
the center of the sacrum was placed at the beam isocenter.
The irradiated region in the pelvis scan consisted of the
colon, ovaries, small intestine, cervix, and bladder. To
ensure reproducibility, cross hairs at the anterior and the
lateral side were marked and always aligned with the
cross line of the laser pointer. 
To measure organ doses, the glass dosimeters were
inserted in the holes of the phantom which are positioned
in the volume of the organs listed in the ICRP (International
Commission on Radiation Protection Publication)-103
recommendations [15]. Table 3 shows all of the organs
investigated and the number of measurement locations used
to evaluate the organ dose.
The average dose to skin was evaluated by placing 6
dosimeters at the center of the anterior and left lateral
marked cross lines for head and neck, chest, and pelvis scan. 
258 NUCLEAR ENGINEERING AND TECHNOLOGY,  VOL.46  NO.2  APRIL 2014
MOON et al., Effective Dose Measurement for Cone Beam Computed Tomography Using Glass Dosimeter
Organ 
Brain 
Esophagus 
Salivary glands
Thyroid  
Lungs
Breast
Stomach
Liver 
Colon 
Gonads  (Ovaries)
Bladder
Bone marrow
Bone surface
Skin
Reminder Organ:
Oral mucosa
Extrathoracic region
Thymus
Heart
Spleen
Adrenals
Pancreas
Gall bladder
Kidneys
Small intestine
Cervix
Phantom slice number
3
6, 11
6
9
13, 17
17
21
21
26
28
32
6, 13, 18, 21, 25, 28, 32
6, 13, 18, 21, 25, 28, 32
6, 18, 30
7
6, 7, 9 
14
18
20
21
21
22
22
24,25
33
Measurement Points
2
2
2
2
4
2
1
1
2
2
1
13
13
6
1
4
1
1
1
2
1
1
2
2
1
Table 3. List of Organs and Tissues Investigated in the Study and the Number of Measurement Points
For small organs, absorbed doses measured near the
center of the organ were adopted as the organ dose. For
larger organs, dosimeters were placed within the volume
of the organ which was evenly subdivided. A mass energy
absorption coefficient obtained from the ICRU (International
Commission on Radiological Unit and measurement)
Report 44 [16] was employed. The organ absorbed dose
was calculated using the following equation:
where Dorgan is dose in the organ, Dair is dose in air, and 
is the ratio of mass energy absorption coefficients
in organ to air. 
2.6 Calculation of Effective Doses
After the calculation of the organ absorbed doses, the
effective dose was evaluated as follows:
where Hg is the effective dose, DRT is the absorbed dose
delivered by radiation type R averaged over organ T, WR
is the radiation-weighting factor, and WT is the tissue-
weighting factor. In our case, the organ dose is simply the
equivalent dose because the radiation weighting factor
for X-rays from CBCT is 1.0. In this study, the effective
dose was derived using only the female physical phantom,
but according to ICRP-103 recommendations the effective
dose is defined for the average of male and female. It must
be noted that the effective dose derived in this study is an
approximation of actual effective dose. Takahiko Aoyama
et al. [19] reported that female and male-specific effective
doses were not significantly different. 
The doses to lymphatic nodes and muscle as remainder
organs listed in ICRP-103 were not measured as in other
previous studies [17] [20]. The fact that these tissues are
evenly distributed across the human body makes it tech-
nically difficult to measure average dose to the tissues.
Nevertheless, these two reminder tissues do not contribute
significantly to the overall effective dose because of their
small tissue weight factors. In conclusion, the average
dose to the other 11 remainder organs was used for the
effective dose evaluation.
3. RESULT AND DISCUSSION 
The organ and effective doses measured using the
standard CBCT mode for the three different treatment sites
(head and neck, chest, and pelvis) are shown in Table 4.
3.1 Head and Neck Scan
The thyroid received a maximum dose of 26.6 mGy,
which was much higher than those of other in-field organs;
the esophagus, salivary glands, oral mucosa, extrathoracic
region, and brain received 12.0, 20.1, 18.4, 23.0, and
17.2 mGy, respectively. The points of measurement for
the thyroid were adjacent to the trachea. The relatively
higher dose in the thyroid is attributed to the reduced X-
ray attenuation through the air cavity and the smaller
diameter of the neck. For organs that were not covered
by the primary beam, the measured doses were much
smaller than those of the in-field organs. The effective dose
in this scan was 3.67 mSv. The relatively higher doses of
the thyroid, salivary glands, and esophagus were major
contributors to the effective dose.
3.2 Chest Scan
The glass dosimeter data showed that the organ dose
within the irradiated site varied from 7.15 to 16.8 mGy.
A maximum dose of 16.8 mGy was found in the thymus,
and the point of measurement was close to the junction
of the aorta and heart. The presence of the lung, neck, and
thin skin layer around the thymus increased the backscat-
tering radiation dose to the tissue. For the points covered
by the primary beam, the glass dosimeter data showed a
mean dose of 14.1 mGy. For the chest scan, the doses to
organs adjacent to the in-field organs ranged from 0.105
to 1.01 mGy. The effective dose from the single CBCT
scan of the chest was estimated to be 7.36 mSv. 
3.3 Pelvis Scan
The bladder received a maximum dose of 13.0 mGy.
A dose of 9.89 mGy was observed in the small intestine.
Doses ranging from 0.0769 to 1.85 mGy were found for
organs that were not irradiated directly by the primary
beam. The average organ dose for the stomach, liver,
adrenals, pancreas, gall bladder, and kidneys adjacent to
the pelvis were relatively higher, up to 1.31 mGy, because
the high density of the pelvis resulted in a high probability
for scattering. The effective dose for the pelvis scan was
4.09 mSv.
3.4 Discussion
Calibration for the energy dependence of the detector
is required to obtain accurate measurement values. In this
study, the GD352M, which was corrected for the high
response in kV energies of X-rays, was calibrated again
for more accurate measurement of the imaging dose from
the XVI system. As a result, the beam quality coefficient
was obtained and the corrected organ dose was 4.0% higher
than the uncorrected organ dose. 
It is important to differentiate the data in this study
from that in other studies. For the XVI system, a small
number of organ dose studies have been reported in the
literature. Islam et al. measured doses using an ion chamber
with MOSFET detectors and cylindrical water phantoms
[21]. The doses were 1.8 to 2.3 cGy for 120 kV in a 30-cm
diameter body phantom and 2.6 to 3.4 cGy for 120 kV in
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(5)
(6)
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a head phantom. The doses depend on the size of the field
of view, measurement depth, and the number of projections
from the CBCT. Sykes et al. reported surface doses from
2.6 to 3.1 cGy for a setting of 130 kV, 40 mA, 14 ms, and
612 projection images in a RANDO® head phantom [22].
However, since these studies do not report organ-specific
doses, it is not useful to compare their results with the organ
doses in our study. Daniel E. Hyer et al. used optical-fiber-
based scintillation detectors to measure effective dose for
XVI and OBI cone-beam CT systems measurement [23].
For the head and neck, chest, and pelvis scan, the effective
doses were 0.04, 7.15, and 3.73 mSv, respectively. The
effective dose for the chest scan completely agrees with
the value evaluated in this study. For the head and neck
and the pelvis scan, the dose difference might be attributed
to a considerable deviation in a setting for the CBCT scan.
Our study shows that the use of CBCT during treatment
will deliver a considerable imaging dose (12.0–26.6 mGy
Organ 
Brain 
Esophagus 
Salivary glands
Thyroid  
Lungs
Breast
Stomach
Liver 
Colon 
Gonads  (Ovaries)
Bladder
Bone marrow
Bone surface
Skin
Reminder Organ:
Oral mucosa
Extrathoracic region
Thymus
Heart
Spleen
Adrenals
Pancreas
Gall bladder
Kidneies
Small intestine
Cervix
Effective Dose
Head and neck scan
17.2±1.3
12.0±0.4
20.1±0.6
26.6±2.0
1.58±0.11
0.337±0.024
0.179±0.009
0.201±0.009
0.0984±0.0238
0.0517±0.0116
0.0445±0.0111
3.95±0.15
21.2±0.7
6.46±1.05 
18.4±0.6
23.0±1.0
1.61±0.05
0.384±0.013 
0.232±0.007
0.170±0.005
0.166±0.005
0.150±0.005
0.141±0.004
0.0917±0.0031
0.0284±0.0011
3.67±0.29 mSv
Absorbed dose per scan (mGy)
Chest scan
0.196±0.027
7.15±0.54
0.479±0.021
1.01±0.06
14.5±1.1
9.16±0.59
14.7±0.6
15.8±0.8
0.872±0.087
0.190±0.022
0.153±0.022
3.64±0.12
19.5±0.6
5.52±0.80 
0.741±0.025
0.915±0.044
16.8±0.5
16.6±0.5
16.0±0.5
14.5±0.4
15.7±0.5
14.6±0.4
14.2±0.4
3.32±0.11
0.105±0.007
7.36±0.33 mSv
Pelvis scan
0.0769±0.0437
0.202±0.048
0.109±0.003
0.122±0.042
0.244±0.066
0.316±0.043
1.04±0.06
1.02±0.06
12.5±0.5 
11.5±0.4
13.0±0.5
5.64±0.18
30.3±1.0
4.57±0.75
0.110±0.003
0.113±0.003
0.156±0.005
0.348±0.011
0.639±0.021
1.10±0.03
1.12±0.03
1.85±0.06
1.78±0.08
9.89±0.33
12.6±0.4
4.09±0.29 mSv
Table 4. Organ Dose and Effective Dose for Head and Neck, Chest, and Pelvis Scans
for head and neck scan, 9.16–16.8 mGy for chest scan,
and 9.89–13.0 mGy for pelvis scan) to organs positioned
in the primary imaging field. Notification about the imaging
dose from the use of CBCT is important when used for
daily position verification. Also it can be reduced through
adjusting the scan parameters and the number of projections
from CBCT. 
4. CONCLUSIONS
The effective dose to patients from the X-ray volumetric
imager attached to a medical LINAC was evaluated. Organ
dose was measured using glass dosimeters, which were
implanted at various organ positions within a RANDO®
Woman phantom. The effective dose was evaluated accord-
ing to the ICRP 103 recommendation. In the CBCT exam-
ination of the head and neck, chest, and pelvis, the organ
doses from the primary beam were 12.0–26.6 mGy, 9.16–
16.8 mGy, and 9.89–13.0 mGy, respectively, and the
effective doses were 3.67 mSv, 7.36 mSv, and 4.09 mSv,
respectively.
Generally, radiation therapy is performed with the
fractions from 10 to 30 [24]. If the prescribed dose (PD) is
60 Gy and one CBCT scan is carried out for one treatment
cycle, the imaging dose for the thyroid from the maximum
dose in a head and neck scan during a 30-fraction treatment
is 1.33% of PD at 79.8 cGy. In particular, the imaging
doses for the thymus in a chest scan and the bladder in a
pelvis scan are 0.84% of PD at 50.4 cGy and 0.65% of
PD at 39.0 cGy, respectively.
The additional effective dose during the 30-fraction
treatment ranged from 110 mSv (head and neck scan) to
220 mSv (chest scan). According to ICRP 103, the prob-
ability of fatal cancer risk from a single radiographic
exposure is 5.5×10-5 per mSv. The effective dose from
110 to 220 mSv could induce an additional secondary
cancer risk of about 0.6 to 1.2%. These data are expected
to be useful in determining the number of CBCT scans
performed in radiotherapy.
In order to clinically use the data, the effective dose
should be evaluated for various scan conditions and scan
sites. Further studies are required for the various scanning
conditions of CBCT and different IGRT LINACS.
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